
The Library Media — Business & Markets · Markets Desk
Germany Markets — Closing Report: BASF walks away from Evonik (Nov 19, 2026)
By Clara Ledger
Image: The Library Media
The DAX closed at 25,463.81, down 272.43 points, or 1.06% (Yahoo Finance supplement, as of 6:00 p.m. CET). The previous close of 25,736.24 reconciles exactly with the closing level and reported point change. The Xetra session ended at 5:30 p.m. CET. The clearest company-specific story in the German market was BASF’s decision to end its pursuit of Evonik after Evonik rejected two takeover offers.
Biggest gainers
BioNxt Solutions Inc. (BXT) +22.50% to 0.172 EUR — Flagged: foreign Canadian listing and micro-cap, with a market capitalization of EUR 27.05 million. No confirmed driver reported for this move.
H2 Core AG (M5S) +21.85% to 0.0725 EUR — Flagged: penny/micro-cap, with a market capitalization of EUR 532,140. No confirmed driver reported for this move.
Insmed Incorporated (IM8N) +20.31% to 131.72 EUR — Flagged: foreign US listing and odd print, with a market capitalization of EUR 28.84 billion. Bloomberg reported that Sanofi is considering a takeover of Insmed; the company’s US shares surged about 16%–19%, according to Yahoo Finance and Investing.com.
Berentzen-Gruppe AG (BEZ) +18.44% to 6.68 EUR — No confirmed driver reported for this move.
hGears AG (HGEA) +17.65% to 0.200 EUR — Flagged: penny/micro-cap, with a market capitalization of EUR 2.08 million. No confirmed driver reported for this move.
Biggest losers
NORMA Group SE (NOEA) -30.35% to 0.530 EUR — Flagged: odd print. The same company’s other Xetra line, NOEJ, traded at EUR 11.88, down 2.62%; the NOEA quote is not a credible representation of the company’s daily move. No confirmed driver reported for this move.
Enovix Corporation (6Q81) -27.75% to 1.276 EUR — Flagged: foreign US listing. Enovix distributed a warrant dividend of one warrant for every four shares on November 18, with the warrants trading separately from November 19; that distribution mechanically separates value from the common shares. Bank of America also downgraded the stock to Underperform, citing concerns about its smartphone battery strategy.
HausVorteil AG (KA1) -21.20% to 3.940 EUR — Flagged: micro-cap, with a market capitalization of EUR 8.78 million. No confirmed driver reported for this move.
CR Energy AG (CRZK) -19.73% to 0.354 EUR — Flagged: penny/micro-cap, with a market capitalization of EUR 517,460. No confirmed driver reported for this move.
Evonik Industries AG (EVK) -16.21% to 18.25 EUR — BASF announced it was ending its pursuit after Evonik rejected two takeover offers, in a potential transaction valued at approximately EUR 11.6 billion–EUR 12 billion. Evonik fell sharply while BASF rose.
StockAnalysis mover figures are as of 6:22 p.m. CET. The current list reflects the later observation supplied for this report; earlier snapshots showed a materially different set of leading decliners. The closing list is used here, rather than combining securities from different readings.
The BASF-Evonik development was the day’s standout German corporate story. BASF’s withdrawal followed two rejected offers, and the market response was sharply divergent: Evonik was among the largest decliners, while BASF gained 2.17% to EUR 53.72. The move in Insmed was another notable corporate development, with takeover speculation involving Sanofi accompanying a sharp rise in the US-listed shares and a corresponding gain in the German line. Enovix’s decline had a separate, documented corporate-action and analyst-rating context. The remaining listed moves do not have confirmed individual catalysts in the supplied information.
The wider European session was weak. Reuters and Kitco described a global equity retreat as investors reassessed the AI trade following Anthropic’s record IPO. European chip and technology shares initially benefited from optimism around the offering before momentum faded. Oil rose on reports of renewed attacks and naval mines affecting tankers in the Strait of Hormuz, while precious metals declined as expectations of Federal Reserve rate increases increased. Those global developments provide context for the DAX’s decline but do not establish causes for the smaller-stock moves.
For the next session, investors will be watching for any further developments in the BASF-Evonik situation and the market’s response to Anthropic’s Nasdaq debut. Oil and shipping developments in the Strait of Hormuz also remain relevant. No additional German earnings release, economic-data publication or central-bank event for the next session was verified in the supplied fact pack.
Clara Ledger
Markets Desk, The Library Media
From The Library — the estate of our family.
Follow Us
